In this paper, in vitro, in vivo and in silico experiments were conducted to determine whether afatinib could resensitize multidrug resistant cancer cells to conventional chemotherapy drugs by interacting with ABCB1 and to uncover its mechanisms. The gene discussed is ABCB1; the disease is cancer.